Results 281 to 290 of about 44,395 (311)
Some of the next articles are maybe not open access.

Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder

Expert Opinion on Pharmacotherapy, 2011
Overactive bladder (OAB) describes complex symptoms, comprising of urinary urgency, with or without urinary incontinence, often with increased daytime frequency and nocturia in the absence of infection or other obvious etiology. OAB is highly prevalent and affects physical and mental health, activities of daily life and the quality of life of millions ...
Latini JM, Giannantoni A.
openaire   +3 more sources

Management of Overactive Bladder

New England Journal of Medicine, 2004
To the Editor: In his review of the management of overactive bladder (Feb. 19 issue),1 Dr. Ouslander states in Table 1 that cholinesterase inhibitors could theoretically contribute to detrusor overactivity, but he suggests that there is no evidence to support this association. Cholinesterase inhibitors are widely used to manage the symptoms of dementia.
Sudeep S, Gill   +2 more
openaire   +4 more sources

Pathophysiology of Overactive Bladder

The American Journal of Medicine, 2006
Overactive bladder (OAB) is a complex of symptoms frequently encountered in the primary care setting. Impediments to optimal management of OAB include inaccurate perceptions on the part of patients and primary care providers, e.g., that the symptoms of OAB represent a natural progression of aging and are beyond the scope of treatment or that diagnosis ...
Franklin M, Chu, Roger, Dmochowski
openaire   +2 more sources

Managing overactive bladder

Climacteric, 2019
Overactive bladder (OAB) is a common and distressing condition which is known to increase with age and has a significant effect on quality of life. Whilst OAB is a symptomatic diagnosis, many patients will require basic investigations prior to initiating the appropriate management. This article will review the initial clinical assessment and management
D, Robinson, L, Cardozo
openaire   +2 more sources

Drugs for Overactive Bladder

The Medical Letter on Drugs and Therapeutics, 2023
In overactive bladder, involuntary bladder contractions due to detrusor overactivity result in urinary urgency, frequency, nocturia, and incontinence. The prevalence of the disorder increases with age. Nonpharmacologic treatment, including bladder training, urge suppression, pelvic floor muscle exercises, constipation management, modification of fluid ...
openaire   +2 more sources

The overactive bladder

Nursing Standard, 2003
The problem of an overactive bladder is common and can have a major impact on patients' lives. This article describes the possible causes of the condition and the interventions available to help to control it.
openaire   +2 more sources

BIOFEEDBACK IN OVERACTIVE BLADDER

BJU International, 2000
ABSTRACT Biofeedback is a form of learning or re‐education in which the participant is retrained within a closed feedback loop. Information about one or more of the patient's normally unconscious physiologic processes is made available to the patient as a visual, auditory, or tactile signal.
openaire   +2 more sources

Biomarkers in overactive bladder

International Urogynecology Journal, 2013
A biomarker is an indicator of a particular disease. It is generally used to define the presence (diagnostic biomarker), severity, progression (prognostic biomarker) of a condition and/or its response to a specific treatment (predictive biomarker). Biomarkers can be specific cells, enzymes, hormones, genes or gene products, which can be detected and ...
Alka A, Bhide   +3 more
openaire   +2 more sources

Overactive bladder in children

Nature Reviews Urology, 2016
Overactive bladder (OAB) is a ubiquitous syndrome that is defined by urinary urgency with, or without urinary incontinence. OAB is observed in all parts of the world, with a prevalence of 5-12% in children (5-10 years of age) and a prevalence of 0.5% in older adolescents (16-18 years of age). Published data indicate that around a third of children with
openaire   +2 more sources

Oxybutynin and the overactive bladder

World Journal of Urology, 2001
Oxybutynin is a tertiary amine, which undergoes an extensive first-pass metabolism. It has an active metabolite, N-desethyl oxybutynin, and the effect of oral oxybutynin is to a large extent exerted by this metabolite. Oxybutynin has both an antimuscarinic and a direct muscle relaxant effect, and, in addition, local anesthetic actions.
K E, Andersson, C R, Chapple
openaire   +2 more sources

Home - About - Disclaimer - Privacy